Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis

NCT03135249 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis (MS)

Interventions

DRUG: Alemtuzumab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]